- Investing Ideas
- /
- U.S. Can They Turn the Tide
U.S. Can They Turn the Tide
UPDATED Apr 23, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
203 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
IVZ | US$14.58 | -4.3% | -13.9% | US$6.6b | US$17.55 | PS1.1x | E38.5% | 5.5% | Diversified Financials | ||
TFC | US$38.84 | 8.9% | 26.9% | US$52.0b | US$42.38 | PB1x | E64.6% | 5.4% | Banks | ||
BANC | US$13.95 | 1.0% | n/a | US$2.3b | US$17.25 | PB0.8x | E137.6% | 2.9% | Banks | ||
SMAR | US$38.29 | 1.6% | -6.6% | US$5.3b | US$49.28 | PS5.5x | E50.5% | n/a | Software | ||
EBC | US$13.08 | 6.9% | 18.6% | US$2.1b | US$16.50 | PB0.7x | E95.5% | 3.4% | Banks | ||
RAMP | US$33.19 | 4.5% | 43.9% | US$2.2b | US$47.75 | PS3.5x | E176.3% | n/a | Software | ||
ENOV | US$55.47 | -1.4% | -2.4% | US$3.0b | US$75.20 | PS1.8x | E83.1% | n/a | Healthcare | ||
ACAD | US$16.74 | -2.6% | -17.6% | US$2.8b | US$29.09 | PS3.8x | E40.9% | n/a | Pharmaceuticals & Biotech | ||
ZETA | US$12.12 | 2.3% | 24.3% | US$2.6b | US$15.35 | PS3.6x | E107.3% | n/a | Software | ||
QRVO | US$107.98 | -1.8% | 20.3% | US$10.4b | US$115.80 | PS3x | E68.7% | n/a | Semiconductors | ||
SYM | US$40.25 | -4.1% | 36.9% | US$23.5b | US$54.27 | PS2.9x | E115.8% | n/a | Capital Goods | ||
CRDO | US$17.59 | -5.4% | 112.4% | US$2.9b | US$26.36 | PS17.5x | E123.6% | n/a | Semiconductors | ||
AXSM | US$73.08 | 4.8% | 4.2% | US$3.5b | US$121.13 | PS12.8x | E59.8% | n/a | Pharmaceuticals & Biotech | ||
ZS | US$176.92 | 2.3% | 90.1% | US$26.5b | US$258.52 | PS14x | E41.1% | n/a | Software | ||
HIMS | US$12.33 | -0.6% | 10.2% | US$2.6b | US$14.94 | PS3x | E44.9% | n/a | Healthcare | ||
SPB | US$80.51 | 1.7% | 26.3% | US$2.4b | US$92.79 | PB1.1x | E50.8% | 2.1% | Household | ||
CLBT | US$10.71 | 3.2% | 100.2% | US$2.2b | US$13.64 | PS7.1x | E55.5% | n/a | Software | ||
EXAS | US$63.53 | 0.5% | 1.4% | US$11.5b | US$89.37 | PS4.6x | E61.9% | n/a | Pharmaceuticals & Biotech | ||
GLBE | US$33.93 | 1.5% | 21.5% | US$5.6b | US$44.07 | PS9.9x | E89.9% | n/a | Retail | ||
BECN | US$97.55 | 4.7% | 70.4% | US$6.2b | US$108.92 | PB3.4x | E61.1% | n/a | Capital Goods | ||
PTVE | US$15.00 | 5.3% | 103.8% | US$2.7b | US$16.86 | PB2x | E74.3% | 2.7% | Materials | ||
BIO | US$285.28 | -1.9% | -34.6% | US$8.1b | US$428.90 | PS3x | E81.3% | n/a | Pharmaceuticals & Biotech | ||
ITCI | US$74.01 | -3.5% | 21.2% | US$7.7b | US$90.28 | PS16.6x | E57.6% | n/a | Pharmaceuticals & Biotech | ||
FIVN | US$60.14 | 5.7% | -3.4% | US$4.4b | US$84.79 | PS4.9x | E64.4% | n/a | Software |